Contact
DMCA
Privacy
Robuta
https://pubmed.ncbi.nlm.nih.gov/35983927/
Melphalan flufenamide for relapsed/refractory multiple myeloma
Despite therapeutic advances and improved patient outcomes in recent years, multiple myeloma (MM) remains a mostly incurable hematologic malignancy. Patients...
melphalan flufenamide
multiple myeloma
relapsed
refractory